Steven Madden Stock Is Up 81%. Should Investors Care About This Director's Sale? Steven Madden, a footwear and accessories leader, reported a notable insider sale amid strong one-year share price performance.
Is PayPal Stock Cheap, or a Value Trap? Although the fintech stock trades at a price-to-earnings ratio of 7.8, there is ongoing debate about its investment merits.
Why This $1.8 Million Dime Insider Sale May Matter Less Than Its 67% EPS Growth This New York regional bank, known for its commercial lending focus, reported significant insider selling in the latest SEC filing.
Where Will Nvidia Stock Be in 2030? The AI build-out turned the chipmaker into a giant -- but how much longer can the spending last?
Intuitive Surgical Stock Is Up Over 400%. Here's Why It's Still a No-Brainer Buy. Intuitive Surgical has been a huge winner over the long term, but there's a potential opening for new investors right now.
A Clover Health Director Sold Over 67,000 Company Shares. Here's a Closer Look at the Transaction. This healthcare technology firm, focused on Medicare Advantage plans, reported a notable insider sale amid muted stock performance.
Vesta Director Sells $203,000 in Stock While Shares Gain 25% in a Year This Mexican industrial real estate firm reported a notable insider sale following a year of strong share price gains and stable growth.
Where Will Solana Be in 3 Years? The world's fastest blockchain could attract a lot more attention.
This Vanguard Index Fund Could Be the Best Financial Decision You Ever Make Setting yourself up for a lifetime of wealth doesn't need to be complicated. Buy this ETF and you'll be well on your way!
Vericel Stock Is Up 10%. Here's What This $402,000 Insider Sale Really Suggests Focused on regenerative therapies for sports medicine and burn care, this biopharma firm reported a notable insider sale in June.
What to Know About This $197,000 Veracyte Insider Sale After a 120% Stock Rally This genomics diagnostics specialist, up over 120% in a year, reported a notable insider sale amid ongoing scheduled dispositions.
This U.S. Uranium Miner Just Became a Critical Minerals Play. But Is the Stock a Buy? Energy Fuels is entering the critical minerals space as the U.S. seeks to secure domestic sources of these important materials.
What to Know About This $3.3 Million Intuitive Machines Insider Sale as Space Stocks Heat Up Houston’s lunar exploration specialist reported a notable insider sale amid ongoing contract-driven growth in the aerospace sector.
How to Save Money on Your Medicare Prescription Drugs Healthcare is one of a retiree's largest expenses. Here are six ways to minimize prescription costs.
Solar Beats Coal for the First Time: 3 Dividend Stocks to Buy Now Solar power generated more electricity than coal in May; this could be a sign to buy clean energy stocks.
What to Know About This $476,000 Palvella Therapeutics Insider Sale After a 620% Stock Rally Focused on rare skin disease therapies, this clinical-stage biotech just reported a notable insider sale amid a year of sharp stock gains.
What to Know About OrbiMed's $39 Million Enliven Therapeutics Stock Sale Amid a 130% Rally Focused on cancer therapies, this Boulder-based biotech reported significant insider selling amid a year of sharp share price gains.
Here's How Investing $450 Per Month Could Generate More Than $30,000 in Annual Dividends The Schwab U.S. Dividend Equity ETF is a solid option for investors who want a quality investment that can generate lots of dividend income.
Starting at $0? Here's How You Can Build Up a $500,000 Portfolio in 25 Years Investing less than $400 per month into a top index fund could be enough to grow your portfolio to over half a million dollars in the long haul.
Trulieve CEO Sells $1.2 Million in Stock as Shares Jump 148% in One Year This vertically integrated cannabis operator reported significant insider selling in its latest SEC disclosure.
Vanguard Total Bond Market ETF Tops iShares 3-7 Year Treasury Bond ETF on Yield and Cost. Does That make BND a Buy? Compare diversification, risk, and performance between these two leading fixed-income ETFs to see which may better suit your portfolio goals.
Here's How Many Shares of Pfizer You Must Own to Get $5,000 in Yearly Dividends The sizable yield comes with a concerning footnote. Just look at the rest of the story.
3 Best Space Stocks to Buy Now Space resilience is becoming a national security priority, and three stocks are fighting for the upside. One may have the broadest long-term opportunity.
What to Know About a Box Insider's $365,000 Stock Sale as Shares Fall 22% This Past Year This cloud content management firm runs a subscription SaaS model; a key insider recently trimmed their stake after a challenging year.
